Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention

INTRODUCTION: Variability in individual response profiles to antiplatelet therapy, in particular clopidogrel, is a well-established phenomenon. Genetic variations of the cytochrome P450 (CYP) 2C19 enzyme, a key determinant in clopidogrel metabolism, have been associated with clopidogrel response pro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Expert Rev Clin Pharmacol
Autors principals: Moon, Jae Youn, Franchi, Francesco, Rollini, Fabiana, Rios, Jose R. Rivas, Kureti, Megha, Cavallari, Larisa H., Angiolillo, Dominick J.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5771818/
https://ncbi.nlm.nih.gov/pubmed/28689434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1353909
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars